Detailed Mechanism Funding and Narrative

Years of mechanism: 2014 2015 2016 2017 2018

Details for Mechanism ID: 17623
Country/Region: Rwanda
Year: 2017
Main Partner: Ministry of Health - Rwanda
Main Partner Program: NA
Organizational Type: Host Country Government Agency
Funding Agency: HHS/CDC
Total Funding: $11,501,776 Additional Pipeline Funding: $6,063,185

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $564,662
Care: TB/HIV (HVTB) $383,061
Care: Pediatric Care and Support (PDCS) $763,856
Laboratory Infrastructure (HLAB) $0
Testing: HIV Testing and Counseling (HVCT) $288,750
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $0
Treatment: Adult Treatment (HTXS) $8,569,038
Treatment: Pediatric Treatment (PDTX) $932,409
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
GEND_GBV By PEP service provision (related to sexual violence services provided) 2018 1,136
GEND_GBV By type of service: Physical and/or Emotional Violence (Other Post-GBV Care) 2018 2,317
GEND_GBV By type of service: Sexual Violence (Post-Rape Care) 2018 3,777
GEND_GBV Number of people receiving post-GBV care 2018 6,100
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2018 833,954
HTS_TST Service Delivery Point (Facility) Pediatric : <5 Negative 2018 1,334
HTS_TST Service Delivery Point (Facility) VMMC: <15, Negative 2018 2,554
HTS_TST Service Delivery Point Agg Age (Facility) Index: <15, Female, Negative 2018 1,072
HTS_TST Service Delivery Point Agg Age (Facility) Index: <15, Male, Negative 2018 940
HTS_TST Service Delivery Point Agg Age (Facility) Index: 15+, Female, Negative 2018 11,983
HTS_TST Service Delivery Point Agg Age (Facility) Index: 15+, Male, Negative 2018 5,142
HTS_TST Service Delivery Point by Agg Age (Community) Index Mod: 15+, Female, Negative 2018 110
HTS_TST Service Delivery Point by Agg Age (Community) Index Mod: 15+, Male, Negative 2018 47
HTS_TST Service Delivery Point by Agg Age (Facility) ANC: 15+, Negative 2018 102,572
HTS_TST Service Delivery Point by Agg Age (Facility) Inpatient: <15, Female, Negative 2018 3,301
HTS_TST Service Delivery Point by Agg Age (Facility) Inpatient: <15, Male, Negative 2018 3,499
HTS_TST Service Delivery Point by Agg Age (Facility) Inpatient: 15+, Female, Negative 2018 55,149
HTS_TST Service Delivery Point by Agg Age (Facility) Inpatient: 15+, Male, Negative 2018 14,292
HTS_TST Service Delivery Point by Agg Age (Facility) Inpatient: Unknown Age, Female, Negative 2018 6
HTS_TST Service Delivery Point by Agg Age (Facility) Other PITC: <15, Female, Negative 2018 9,292
HTS_TST Service Delivery Point by Agg Age (Facility) Other PITC: <15, Male, Negative 2018 8,561
HTS_TST Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Female, Negative 2018 254,367
HTS_TST Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Male, Negative 2018 59,743
HTS_TST Service Delivery Point by Agg Age (Facility) TB: <15, Female, Negative 2018 466
HTS_TST Service Delivery Point by Agg Age (Facility) TB: <15, Male, Negative 2018 476
HTS_TST Service Delivery Point by Agg Age (Facility) TB: 15+, Female, Negative 2018 7,872
HTS_TST Service Delivery Point by Agg Age (Facility) TB: 15+, Male, Negative 2018 1,675
HTS_TST Service Delivery Point by Agg Age (Facility) VCT: <15, Female, Negative 2018 6,780
HTS_TST Service Delivery Point by Agg Age (Facility) VCT: <15, Male, Negative 2018 6,811
HTS_TST Service Delivery Point by Agg Age (Facility) VCT: 15+, Female, Negative 2018 107,854
HTS_TST Service Delivery Point by Agg Age (Facility) VCT: 15+, Male, Negative 2018 116,619
HTS_TST Service Delivery Point by Agg Age (Facility) VMMC: 15+, Negative 2018 31,475
HTS_TST Service Delivery Point by Agg Age(Community) Mobile Testing: 15+, Female, Negative 2018 7,902
HTS_TST Service Delivery Point by Agg Age(Community) Mobile Testing: 15+, Male, Negative 2018 2,930
HTS_TST Sum of Test Result disaggregates 2018 6,128
HTS_TST_POS By Test Result: Positive 2018 6,128
HTS_TST_POS Service Delivery Point Agg Age (Facility) Index: <15, Female, Positive 2018 110
HTS_TST_POS Service Delivery Point Agg Age (Facility) Index: <15, Male, Positive 2018 89
HTS_TST_POS Service Delivery Point Agg Age (Facility) Index: 15+, Female, Positive 2018 2,152
HTS_TST_POS Service Delivery Point Agg Age (Facility) Index: 15+, Male, Positive 2018 2,061
HTS_TST_POS Service Delivery Point by Agg Age (Community) Index Mod: 15+, Female, Positive 2018 22
HTS_TST_POS Service Delivery Point by Agg Age (Community) Index Mod: 15+, Male, Positive 2018 8
HTS_TST_POS Service Delivery Point by Agg Age (Facility) ANC: 15+, Positive 2018 761
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Inpatient: <15, Female, Positive 2018 57
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Inpatient: <15, Male, Positive 2018 39
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Inpatient: 15+, Female, Positive 2018 420
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Inpatient: 15+, Male, Positive 2018 169
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Other PITC: <15, Female, Positive 2018 24
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Other PITC: <15, Male, Positive 2018 20
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Female, Positive 2018 1,100
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Male, Positive 2018 1,456
HTS_TST_POS Service Delivery Point by Agg Age (Facility) TB: <15, Female, Positive 2018 7
HTS_TST_POS Service Delivery Point by Agg Age (Facility) TB: <15, Male, Positive 2018 10
HTS_TST_POS Service Delivery Point by Agg Age (Facility) TB: 15+, Female, Positive 2018 116
HTS_TST_POS Service Delivery Point by Agg Age (Facility) TB: 15+, Male, Positive 2018 150
HTS_TST_POS Service Delivery Point by Agg Age (Facility) VCT: <15, Female, Positive 2018 29
HTS_TST_POS Service Delivery Point by Agg Age (Facility) VCT: <15, Male, Positive 2018 23
HTS_TST_POS Service Delivery Point by Agg Age (Facility) VCT: 15+, Female, Positive 2018 1,310
HTS_TST_POS Service Delivery Point by Agg Age (Facility) VCT: 15+, Male, Positive 2018 1,110
HTS_TST_POS Service Delivery Point by Agg Age (Facility) VMMC: <15, Positive 2018 7
HTS_TST_POS Service Delivery Point by Agg Age (Facility) VMMC: 15+, Positive 2018 273
HTS_TST_POS Service Delivery Point by Agg Age(Community) Mobile Testing: 15+, Female, Positive 2018 319
HTS_TST_POS Service Delivery Point by Agg Age(Community) Mobile Testing: 15+, Male, Positive 2018 72
PMTCT_ART Already on ART at beginning of current pregnancy 2018 2,530
PMTCT_ART New on ART 2018 795
PMTCT_ART Number of HIV-positive pregnant women who received ART to reduce risk of mother-to-child-transmission (MTCT) during pregnancy 2018 3,325
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 106,377
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2018 3,260
PMTCT_EID Number of infants with a negative virological test result between 2 and 12 months of birth 2018 237
PMTCT_EID Number of infants with a negative virological test result within 2 months of birth 2018 2,277
PMTCT_EID Number of infants with a positive virological test result between 2 and 12 months of birth 2018 22
PMTCT_EID Number of infants with a positive virological test result within 2 months of birth 2018 19
PMTCT_EID Unknown, <= 2 months 2018 641
PMTCT_EID Unknown, 2 - 12 months 2018 64
PMTCT_STAT By Age (Numerator): Unknown Age 2018 88,505
PMTCT_STAT By Number of known positives: Unknown Age 2018 2,635
PMTCT_STAT By Number of new negative: Unknown Age 2018 102,287
PMTCT_STAT By Number of new positives: Unknown Age 2018 779
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 106,377
PMTCT_STAT_den By Age (Denominator): Unknown Age 2018 107,963
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 1
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 312
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 1
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 191
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2018 512
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2018 512
TB_ART_den Aggregated Age/Sex: Female <15 (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 2
TB_ART_den Aggregated Age/Sex: Female 15+ (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 310
TB_ART_den Aggregated Age/Sex: Male <15 (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 1
TB_ART_den Aggregated Age/Sex: Male 15+ (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 191
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 27
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 989
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 18
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 694
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2018 1,748
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2018 1,753
TB_STAT_den Aggregated Age/Sex: Female <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 25
TB_STAT_den Aggregated Age/Sex: Female 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 999
TB_STAT_den Aggregated Age/Sex: Male <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 20
TB_STAT_den Aggregated Age/Sex: Male 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 708
TX_CURR Age/Sex: <1 2018 103
TX_CURR Age/Sex: <1-9 2018 2,137
TX_CURR Age/Sex: 10-14 Female 2018 1,568
TX_CURR Age/Sex: 10-14 Male 2018 1,575
TX_CURR Age/Sex: 15-19 Female 2018 3,739
TX_CURR Age/Sex: 15-19 Male 2018 2,437
TX_CURR Age/Sex: 20-24 Female 2018 7,306
TX_CURR Age/Sex: 20-24 Male 2018 2,921
TX_CURR Age/Sex: 25-49 Female 2018 42,721
TX_CURR Age/Sex: 25-49 Male 2018 23,059
TX_CURR Age/Sex: 50+ Female 2018 12,297
TX_CURR Age/Sex: 50+ Male 2018 10,098
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2018 110,041
TX_CURR Sum of age/sex disaggregates 2018 6,176
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2018 199
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2018 188
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2018 7,721
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2018 4,494
TX_NEW Breastfeeding status 2018 815
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2018 12,610
TX_NEW Pregnancy status 2018 826
TX_NEW Sum of Aggregated Age/Sex disaggregates 2018 12,602
TX_PVLS <15, Undocumented Test Indication, Female 2018 86
TX_PVLS <15, Undocumented Test Indication, Female 2018 95
TX_PVLS <15, Undocumented Test Indication, Male 2018 97
TX_PVLS <15, Undocumented Test Indication, Male 2018 109
TX_PVLS 15+, Undocumented Test Indication, Female 2018 2,297
TX_PVLS 15+, Undocumented Test Indication, Female 2018 2,518
TX_PVLS 15+, Undocumented Test Indication, Male 2018 1,358
TX_PVLS 15+, Undocumented Test Indication, Male 2018 1,452
TX_PVLS Breastfeeding, Undocumented Test Indication 2018 4
TX_PVLS Breastfeeding, Undocumented Test Indication 2018 5
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2018 84,161
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2018 78,255
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Female Routine 2018 1,477
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Female Targeted 2018 282
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Male Routine 2018 1,633
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Male Targeted 2018 307
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 37,833
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Female Targeted 2018 7,097
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 21,497
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Male Targeted 2018 4,037
TX_PVLS Numerator: Indication: Routine 2018 62,611
TX_PVLS Numerator: Indication: Targeted 2018 11,735
TX_PVLS Numerator: Preg/BF by Indication: Breastfeeding Routine 2018 59
TX_PVLS Numerator: Preg/BF by Indication: Breastfeeding Targeted 2018 4
TX_PVLS Numerator: Preg/BF by Indication: Pregnant Routine 2018 2,257
TX_PVLS Numerator: Preg/BF by Indication: Pregnant Targeted 2018 141
TX_PVLS Pregnant, Undocumented Test Indication 2018 141
TX_PVLS Pregnant, Undocumented Test Indication 2018 139
TX_PVLS Undocumented Test Indication 2018 3,909
TX_PVLS Undocumented Test Indication 2018 4,186
TX_PVLS Unknown Age, Undocumented Test Indication, Female 2018 1
TX_PVLS Unknown Age, Undocumented Test Indication, Female 2018 1
TX_PVLS Unknown Age, Undocumented Test Indication, Male 2018 1
TX_PVLS Unknown Age, Undocumented Test Indication, Male 2018 1
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Routine 2018 1,591
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Targeted 2018 297
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Routine 2018 1,770
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Targeted 2018 330
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 40,898
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Targeted 2018 7,648
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 23,015
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Targeted 2018 4,324
TX_PVLS_den Denominator: Indication: Routine 2018 67,292
TX_PVLS_den Denominator: Indication: Targeted 2018 12,611
TX_PVLS_den Denominator: Preg/BF by Indication: Breastfeeding Routine 2018 73
TX_PVLS_den Denominator: Preg/BF by Indication: Breastfeeding Targeted 2018 12
TX_PVLS_den Denominator: Preg/BF by Indication: Pregnant Routine 2018 2,390
TX_PVLS_den Denominator: Preg/BF by Indication: Pregnant Targeted 2018 442
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 442
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 394
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 8,987
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 4,923
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2018 14,756
TX_RET Numerator by Status: Breastfeeding 2018 1,144
TX_RET Numerator by Status: Pregnant 2018 1,129
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2018 15,422
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 466
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 415
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 9,383
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 5,155
TX_RET_den Denominator by Status: Breastfeeding 2018 1,180
TX_RET_den Denominator by Status: Pregnant 2018 1,180
TX_TB Number of ART patients who were screened for TB at least once during the reporting period 2018 108,975
TX_TB Number of ART patients who were started on TB treatment during the reporting period 2018 581
TX_TB Numerator: By Aggregated Age/Sex: <15, Female 2018 5
TX_TB Numerator: By Aggregated Age/Sex: <15, Male 2018 5
TX_TB Numerator: By Aggregated Age/Sex: 15+, Female 2018 335
TX_TB Numerator: By Aggregated Age/Sex: 15+, Male 2018 236
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Female 2018 2,555
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Male 2018 2,537
TX_TB_den Denominator: By Aggregated Age/Sex:15+, Female 2018 65,855
TX_TB_den Denominator: By Aggregated Age/Sex:15+, Male 2018 37,345
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Gene Xpert MTB / R if Assay 2018 3,250
TX_TB_den Denominator: By Screen Result: Negative 2018 105,044
TX_TB_den Denominator: By Screen Result: Positive 2018 3,269
TX_TB_den Denominator: Number of ART patients who had a specimen sent for bacteriologic diagnosis of active TB disease 2018 3,222
VMMC_CIRC By Age: 15-19 2018 18,540
VMMC_CIRC By Age: 20-24 2018 8,043
VMMC_CIRC By Age: 25-29 2018 4,323
VMMC_CIRC By circumcision technique: Device-based VMMC 2018 18,595
VMMC_CIRC By circumcision technique: Surgical VMMC 2018 12,315
VMMC_CIRC Number of males circumcised as part of the voluntary medical male circumcision (VMMC) for HIV prevention program within the reporting period 2018 30,910
VMMC_CIRC Sum of age disaggregates (FY15-Current) 2018 30,906
VMMC_CIRC Sum of age disaggregates (Prior to FY15) 2018 26,583
Cross Cutting Budget Categories and Known Amounts Total: $210,386
Key Populations: MSM and TG $25,159
Training of health workers and community outreach workers
Implementation of core HIV prevention interventions for MSM/TG that are consistent with the current PEPFAR technical guidance
Key Populations: Sex Workers $35,222
Implementation of core HIV prevention interventions for SWs consistent with PEPFAR guidance on sexual prevention
Training of health workers and community outreach workers
Gender: Gender Based Violence (GBV) $60,000
GBV Prevention
Human Resources for Health $85,930
Food and Nutrition: Policy, Tools, and Service Delivery $4,075